Free Trial

Atb Cap Markets Downgrades Canopy Growth (NASDAQ:CGC) to Strong Sell

Canopy Growth logo with Medical background
Remove Ads

Atb Cap Markets cut shares of Canopy Growth (NASDAQ:CGC - Free Report) from a hold rating to a strong sell rating in a report released on Monday,Zacks.com reports.

Canopy Growth Trading Down 7.2 %

NASDAQ:CGC traded down $0.22 on Monday, reaching $2.83. The company's stock had a trading volume of 4,994,473 shares, compared to its average volume of 7,454,620. The firm has a market cap of $308.31 million, a PE ratio of -0.57 and a beta of 0.83. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.07 and a current ratio of 1.39. The business's 50-day moving average price is $4.13 and its two-hundred day moving average price is $5.46. Canopy Growth has a 1-year low of $2.76 and a 1-year high of $14.92.

Institutional Investors Weigh In On Canopy Growth

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC bought a new position in shares of Canopy Growth in the third quarter valued at $1,882,000. Headlands Technologies LLC lifted its stake in Canopy Growth by 36,747.5% in the second quarter. Headlands Technologies LLC now owns 117,912 shares of the company's stock valued at $761,000 after acquiring an additional 117,592 shares during the last quarter. Squarepoint Ops LLC grew its position in shares of Canopy Growth by 168.6% in the 2nd quarter. Squarepoint Ops LLC now owns 91,227 shares of the company's stock valued at $588,000 after acquiring an additional 57,262 shares during the period. Centiva Capital LP acquired a new position in shares of Canopy Growth during the 3rd quarter worth about $257,000. Finally, AdvisorShares Investments LLC raised its holdings in shares of Canopy Growth by 86.7% in the 2nd quarter. AdvisorShares Investments LLC now owns 68,922 shares of the company's stock valued at $440,000 after purchasing an additional 32,000 shares during the period. 3.33% of the stock is owned by institutional investors.

Remove Ads

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Recommended Stories

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads